Cervicovaginal cytological abnormalities in patients with human immunodeficiency virus infection, in relation to disease stage, CD4 cell count and viral load

Diagnostic Cytopathology

Volumn 37, Issue 3, 2009, Pages 164-169

  Micheletti, Adilha Misson Rua ^a   De Freitas Dutra, Valéria ^a   Murta, Eddie Fernando Cândido ^a   Paschoini, Marina Carvalho ^a   Silva Vergara, Mário Leon ^a   Silva, Gisele Barbosa E ^a   Adad, Sheila Jorge ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

AIDS; Cervicovaginal smear; HPV; SIL

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CANDIDA; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GARDNERELLA VAGINALIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MEDICAL SCHOOL; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; TRICHOMONAS VAGINALIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINITIS; VIRUS INFECTIVITY; VIRUS LOAD; ANIMAL; CHLAMYDIA; CLASSIFICATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADULT; ANIMALS; CANDIDA; CARCINOMA, SQUAMOUS CELL; CD4 LYMPHOCYTE COUNT; CHLAMYDIA; FEMALE; GARDNERELLA VAGINALIS; HIV INFECTIONS; HUMANS; TRICHOMONAS VAGINALIS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VAGINOSIS, BACTERIAL; VIRAL LOAD;

EID: 64249162083     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20892     Document Type: Article

References (35)

1. Provencher D, Valme B, Averette HE, Ganjei P, Donato D, Penalver M, Sevin BU. HIV status and positive Papanicolau screening: identification of a high-risk population. Gynecol Oncol 1988;31:184-188.
2. Maiman M, Fruchter RG, Serur E, Remy JC, Feuer G, Boyce J. Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol 1990;38:377-382.
3. Schiffman MH, Brinton LA. The epidemiology of cervical carcino-genesis. Cancer 1995;76:1888-1901.
4. Sun XW, Ellerbrock TV, Lungu O, Chiasson MA, Bush TJ, Wright TC, Jr. Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstetric Gynecol 1995;85:680-686.
5. Cu-uvin S, Hogan JW, Warren D, Klein RS, Peipert J, Schuman P, Holmberg S, Anderson J, Schoenbaum E, Vlahov D, Mayer KH. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV epidemiology research study group. Clin Infect Dis 1999;29:1145-1150.
6. Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, Burns D, Greenblatt RM, Muderspach LI, Miotti P. Prevalence and predictors of squamous cell abnormalities in papanico-laou smears from women infected with hiv-1. Women interagency HIV study group. J Acquired Immune Deficiency Syndromes 1999;21:33-41.
7. Sanjose S, Valls I, Cañadas MP, Lloveras B, Quintana MJ, Shah KV, Bosch FX. Infección por los virus del papiloma humano y de la inmu-nodeficiencia humana como factores de riesgo para el cancer de cuello uterino en mujeres reclusas. Medicina Clinica 2000;115:81-84.
8. Auge APF, Piato S, Frade AB, Paes RP, Moura CMC, Santos ALD, Vaz A. Freqüência de neoplasia intra-epitelial cervical em portado-ras do vírus da imunodeficiência humana. Revista Brasileira de Ginecologia e Obstetrícia 2000;22:573-577.
9. Duerr A, Kieke B, Warren D, Shah K, Burk R, Peipert JF, Schuman P, Klein RS. Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstetric Gynecol 2001;184:584-590.
10. Levi JE, Fink MCS, Canto CLM, Carretiero N, Matsubara R, Lin-hares I, Dores GB, Castelo A, Segurado A, Uip DE, Neto JE. Human Papillomavirus prevalence, viral load and cervial intraepi-thelial neoplasia in HIV-infected women. Braz J Infectious Dis 2002;6:129-135.
11. Carlucci M, Cimmino A, Fiore MG, Lepera A, Tantimonaco L, Ricco R. The pap test in HIV-positive women. Pathologica 2001;93:651-653.
12. Feingold AR, Vermund SH, Burk RD, Kelley KF, Schrager LK, Schreiber K, Munk G, Friedland GH, Klein RS. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquired Immune Deficiency Syndrome 1990;3:896-903.
13. Coelho RA, Facundo MKF, Nogueira AL, Sakano CRSB, Ribalta JCL, Bacarat EC. Association of cervical intraepithelial neoplasia with CD4 T cell counts and viral load in HIV-infected women. Revista Brasileira de Ginecologia e Obstetrícia 2004;26:97-102.
14. Kapiga SH, Msamanga GI, Spiegelman D, Mwakyoma H, Fawzi WW, Hunter DJ. Risk factors for cervical squamous intraepitelial lesions among HIV-1 seropositive women in Dar es Salaam, Tanzania. Int J Gynecol Obstetrics 1999;67:87-94.
15. Piper MA, Severin ST, Wiktor SZ, Unger ER, Ghys PD, Miller DL, Horowitz IR, Greenberg AE, Reeves WC, Vernon SD. Association of human papillomavrius with HIV and CD4 cell count in women with high or low numbers of sex partners. Sex Trans Infections 1999;75:253-257.
16. Ahdieh L, Klein RS, Burk R, Cu-uvin S, Schuman P, Duerr A, Safaeian M, Stemborski J, Daniel R, Shah K. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infectious Dis 2001;184:682-690.
17. Massad LS, Ahdieh L, Benning L, Minkoff H, Greenblatt RM, Watts H, Miotti P, Anastos K, Moxley M, Muderspach LI, Melnick S. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study. J Acquired Immune Deficiency Syndromes 2001;27:432-442.
18. Vernon SD, Unger ER, Piper MA, Severin ST, Wiktor SZ, Ghys PD, Miller DL, Horowitz IR, Greenberg AE, Reeves WC. HIV and human papillomavirus as independent risk factor for cervical neo-plasia in women with high or low numbers of sex partners. Sex Trans Infectious 1999;75:258-260.
19. Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, Muderspach L, Burk R, Palefsky J. The effect of highly active anti-retroviral therapy on cervical cytologic changes associated with onco-genic HPV among HIV-infected women. AIDS 2001;15:2157-2164.
20. Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD. Early regression of cervical lesions in HIV-seropositive women receiving highly active anti-retroviral therapy. AIDS 1998;12:1459-1464.
21. Orlando G, Fasolo MM, Schiavini M, Signori R, Cargnel A. Role of highly active anti-retroviral therapy in human papillomavirus-induced genital dysplasia in HIV-1 infected patients. AIDS 1999;13:424-425.
22. Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, Mastrorilli E, Taccagni G, Lazzarin A, Foppa CU. Human papillo-mavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active anti-ret-roviral therapy. Journal Infectious Dis 2001;184:547-551.
23. International Collaboration on HIV and Cancer. Highly active anti-retroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000;92:1823-1830.
24. Solomon D, Nayar R. The Bethesda system for reporting cervical cytology: Definitions, criteria and explanatory notes. New York: Springer-Verlag; 2001. 192 p.
25. Williams AB, Andrews S, Tashima K, Mezger J, Yu C. Factors associated with vaginal yeast infections in HIV-positive women. J Assoc Nurses AIDS Care 1998;9:47-52.
26. Cohn SE, Clark RA. Sexually transmitted diseases, HIV, and AIDS in women. Medical Clin N Am 2003;87:971-995.
27. Williams AB. Gynecologic care for women with HIV infection. J Obstetric Gynecol Neonatal Nursing 2003;32:87-93.
28. Anorlu R, Imosemi D, Odunukwe N, Abudu O, Otuonye M. Prevalence of HIV among women with vaginal discharge in a gynecological clinic. J Natl Med Assoc 2004;96:367-371.
29. Jamieson DJ, Duerr A, Klein RS, Paramsothy P, Brown W, Cu-uvin S, Rompalo A, Sobel J. Longitudinal analysis of bacterial vaginosis: Findings from the HIV epidemiology research study. Obstetric Gynecol 2001;98:656-663.
30. Laga M, Icenogle JP, Marsella R, Manora AT, Nzila N, Ryder RW, Vermund SH, Heyward WL, Nelson A, Reeves WC. Genital papillo-mavirus infection and cervical dysplasia-opportunistic complications of HIV infection. Int J Cancer 1992;50:45-48.
31. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, Wright TC, Jr. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. J Am Med Assoc 2000;283:1031- 1037.
32. Petry KU, Scheffel D, Bode U, Gabrysiak T, Köchel H, Kupsch E, Glaubitz M, Niesert S, Kühnle H, Schedel I. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer 1994;57:836-840.
33. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC, Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343- 1349.
34. Schuman P, Ohmit SE, Klein RS, Duerr A, Cu-uvin S, Jamieson DJ, Anderson J, Shah KV. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-sero-positive and at-risk HIV-seronegative women. J Infectious Dis 2003;188:128-36.
35. Sanjose S, Palefsky J. Cervical and anal HPV infections in HIV positive women and men. Virus Research 2002;89:201-211.